Loading...

AMSF: Financial Tailwinds And Reduced Catastrophe Losses Will Support Share Performance

Published
24 Sep 24
Updated
14 Apr 26
Views
38
14 Apr
US$30.85
AnalystConsensusTarget's Fair Value
US$38.67
20.2% undervalued intrinsic discount
Loading
1Y
-33.6%
7D
-1.7%

Author's Valuation

US$38.6720.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 14 Apr 26

Fair value Decreased 23%

AMSF: Premium Trends And Rebased P/E Are Expected To Drive Future Repricing

Analysts have reduced their price targets on AMERISAFE by about $11 to around $39. They cite recent earnings results in which higher accident year losses and revised growth and profitability assumptions are partially offset by higher premium growth and a recalibrated future P/E outlook.

Analyst Commentary

Bullish Takeaways

  • Bullish analysts point to higher premium growth as a key support for earnings power, which they see as helping to backstop the stock’s current valuation even after the recent target cuts.
  • The view that the shares are fairly valued suggests some confidence that current pricing already reflects recent earnings pressures, leaving room for execution to drive potential upside if results stabilize.
  • Recalibrated P/E expectations incorporate updated assumptions, and bullish analysts see this as creating a clearer link between future earnings delivery and potential share price performance.
  • Despite the Q4 earnings miss, analysts highlighting the offset from premium growth see a more balanced risk and reward profile rather than a purely negative story.

Bearish Takeaways

  • Bearish analysts have reduced price targets, including cuts to around the mid US$30s range, reflecting more cautious views on how recent earnings relate to future shareholder returns.
  • Higher accident year losses weigh on confidence in the company’s underwriting execution, with concerns that similar outcomes could pressure profitability if they persist.
  • Revised assumptions for growth and profitability suggest that prior expectations were too optimistic, leading to a reset in what analysts are willing to pay for the stock.
  • The decision to maintain a Hold stance signals hesitation to assign a higher valuation multiple until there is clearer evidence that premium growth can consistently offset loss trends.

What's in the News

  • AMERISAFE's Board of Directors approved a 5.1% increase in the quarterly dividend, from US$0.39 to US$0.41 per share. The new dividend is payable on March 20, 2026 to shareholders of record on March 13, 2026 (Key Developments).
  • From October 1, 2025 to December 31, 2025, AMERISAFE repurchased 197,672 shares for US$7.96 million, representing 1.04% of the company (Key Developments).
  • The company completed a repurchase of 200,437 shares in total under the buyback announced on July 24, 2025, representing 1.06% of the company for US$8.08 million (Key Developments).

Valuation Changes

  • Fair Value: reduced from $50.00 to about $38.67, a cut of roughly 22.7% that aligns with the lower analyst price targets.
  • Discount Rate: effectively unchanged at about 6.98%, indicating the required return assumption has stayed consistent.
  • Revenue Growth: revised from 5.09% to about 4.09%, reflecting a more cautious outlook on top line expansion.
  • Net Profit Margin: adjusted from 9.20% to about 10.03%, implying an expectation for slightly stronger profitability on each $ of revenue.
  • Future P/E: reduced from about 33.3x to 23.7x, a sizeable reset that ties the valuation more closely to updated earnings assumptions.
2 viewsusers have viewed this narrative update

Key Takeaways

  • Strong growth in policies and voluntary premiums, supported by agent partnerships and technology investment, is driving revenue expansion and margin improvement.
  • High retention, disciplined risk selection, and prudent capital management are supporting long-term earnings stability and attractive shareholder returns.
  • Ongoing pricing pressure, rising costs, and slower policy growth threaten AMERISAFE's premium revenue, profitability, and long-term earnings potential.

Catalysts

About AMERISAFE
    An insurance holding company, underwrites workers’ compensation insurance in the United States.
What are the underlying business or industry changes driving this perspective?
  • Robust policy count growth (3.4% in the quarter, 5.8% year-to-date) and voluntary premium growth (12.8% in the quarter) indicate AMERISAFE is effectively increasing its addressable market by leveraging operational efficiency and deep agent partnerships, which positions the company to drive top-line revenue expansion.
  • The ongoing investment in technology, agent effectiveness, and process scalability supports more efficient underwriting and claims management, which should help lower expense ratios and sustain or improve net margins over the long-term.
  • Strong renewal retention (93.8%) and disciplined risk selection in high-hazard sectors are likely to sustain attractive combined ratios and above-industry underwriting profit margins, bolstering long-term earnings stability.
  • The company's prudent capital management-demonstrated through consistent share repurchases and dividends-enhances shareholder returns and supports book value per share growth, positively impacting valuation multiples.
  • Industry-wide increases in medical severity and regulatory shifts could harden the workers' comp market, benefitting specialized players like AMERISAFE who can adapt quickly, thereby driving future premium growth and supporting net income resilience.
AMERISAFE Earnings and Revenue Growth

AMERISAFE Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming AMERISAFE's revenue will grow by 4.1% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 14.9% today to 10.0% in 3 years time.
  • Analysts expect earnings to reach $35.9 million (and earnings per share of $1.88) by about April 2029, down from $47.1 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 23.8x on those 2029 earnings, up from 13.4x today. This future PE is greater than the current PE for the US Insurance industry at 11.5x.
  • Analysts expect the number of shares outstanding to decline by 1.34% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.98%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The long-term decline in approved workers' compensation loss costs (down mid-single digits year-after-year) signals ongoing pricing pressure in the industry; if this persists, it may continue to compress AMERISAFE's premium rates and constrain top-line revenue growth, especially as wage inflation no longer outpaces rate declines.
  • The company's policy count growth has been achieved with a significant reduction in agent count (from 2,200 to ~1,600 in under two years), which may indicate challenges in sustaining new business momentum going forward, potentially slowing future premium and revenue growth.
  • Rising medical severity costs (up 6% industry-wide according to NCCI) are placing upward pressure on the company's core 71% accident year loss ratio target, which management acknowledges may face additional strain if these trends continue, risking future net margin and underwriting profitability.
  • Audit premium, a material contributor to net premiums earned, has declined meaningfully compared to prior years; as this source of "immediate" premium continues to moderate, it could further weigh on premium revenue and the company's ability to offset soft market conditions.
  • Expense ratios have risen (31.3% in the quarter vs. 29.8% prior year), with continued investment in growth initiatives and higher insurance-based assessments; if top-line growth stalls or operational efficiency gains do not materialize, persistently elevated expense ratios could erode earnings and limit long-term profit expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $38.67 for AMERISAFE based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $45.0, and the most bearish reporting a price target of just $35.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $357.8 million, earnings will come to $35.9 million, and it would be trading on a PE ratio of 23.8x, assuming you use a discount rate of 7.0%.
  • Given the current share price of $33.63, the analyst price target of $38.67 is 13.0% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on AMERISAFE?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives